COMP <GO>
IDYA vs BHC // DIVIDEND YIELD & FCF PAYOUT SAFETY
IDEAYA Biosciences Inc. (NASDAQ) VS. Bausch Health Companies Inc. (NYSE) • 15-METRIC TALLY: IDYA 3
— BHC 6
■ METRIC PARITY
LAST: $31.64 (-1.00%) • MKT CAP: $3.08B
dividend-safety
0.00%
LAST: $8.02 (-2.19%) • MKT CAP: $3.07B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IDYA VS. BHC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IDYA | BHC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.80% | 7.60% | -21.40 | BHC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 10.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.31% | 22.00% | -24.31 | BHC | /fcf-yield <GO> |
| Operating Margin | -60.00% | 17.70% | -77.70 | BHC | /operating-margins <GO> |
| Net Profit Margin | -52.00% | 1.50% | -53.50 | BHC | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 6.70% | +173.30 | IDYA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 21.49 | 0.45 | +21.04 | IDYA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 9/9 | -5.00 | BHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.7 | 64.8 | -28.10 | BHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.97 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 19.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.08B | $3.07B | $14.8M | IDYA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IDYA REV | BHC REV | IDYA GROSS % | BHC GROSS % | IDYA FCF | BHC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $218.7M | $10.27B | — | — | -$73.5M | $1.00B |
| FY 2024 | $7.0M | $9.63B | — | — | -$251.4M | $1.26B |
| FY 2023 | $23.4M | $8.76B | — | — | -$115.2M | $637.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IDYA // BETA —
BHC // BETA 0.97